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Preamble
It is becoming more apparenteach day that despite a
strong nationalcommitment to excellence in health care,
the resources and personnel are finite. It is, therefore, ap-
propriatethat the medicalprofessionexamine the impact of
developing technology on the practice and cost of medical
care. Such analysis, carefully conducted, could potentially
impact on the cost of medical care withoutdiminishingthe
effectiveness of that care.
To this end, theAmerican College of Cardiology and
the AmericanHeartAssociation in 1980 establisheda Task
Force onAssessmentof CardiovascularProcedureswith the
following charge:
The Task Force of theAmerican College of Cardiology
and the American Heart Association shall define the
role of specific noninvasive and invasive procedures
in the diagnosis and management of cardiovascular
disease.
The Task Force shalladdress,when appropriate,the con-
tribution, uniqueness, sensitivity, specificity, indica-
tions, contraindicationsand cost-effectiveness of such
specific procedures.
The Task Force shall include aChairmanand four mem-
bers, tworepresentativesfrom theAmericanHeart As-
sociation and two representativesfrom the American
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College of Cardiology. The Task Force may select ad
hoc members as needed upon theapprovalof the Pres-
idents of bothorganizations.
Recommendationsof the Task Force areforwardedto the
Presidentof each organization.
The members of the Task Force are: Roman W. De-
Sanctis, MD, Harold T. Dodge, MD, T. Joseph Reeves,
MD, Sylvan Lee Weinberg, MD and CharlesFisch, MD,
Chairman.
The Subcommitteeon Nuclear Imaging was chaired by
Robert A.O'Rourke,MD, andincludedthe following mem-
bers: KanuChatterjee,MD, Harold T.Dodge, MD, Charles
Fisch, MD, HerbertJ. Levine, MD, Gerald M. Pohost,
MD, and LeonResnekov, MD.
This document was reviewed by the officers andother
responsible individuals of the two organizations and re-
ceived final approval in April 1986.it is being published
simultaneouslyin Circulation and Journal of the American
College of Cardiology. The potential impact of this docu-
ment on the practice ofcardiology and some of its una-
voidable shortcomingsareclearlyset out in theIntroduction.
CharlesFisch, MD, FACC
Introduction
The American College of Cardiology/AmericanHeart
Association Task Force onAssessment of Cardiovascular
Procedureswas formed to makerecommendationsregarding
the appropriateutilization of technology in the diagnosis
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and treatmentof patients with cardiovasculardisease. One
such importanttechnology is cardiac radionuclideimaging
(nuclearcardiology). Radionuclideimaging proceduresfor
evaluating the cardiovascularsystem have evolved during
the past 20 years from aprimarilyinvestigative phase to a
widely applied clinical phase (1-3). However, many of
these proceduresand theirapplicationsneed further refine-
ment, and some requirecontinuedinvestigationto prove or
disprove their clinical utility. Accordingly, the Subcom-
mittee on Nuclear Imaging was given the assignment of
defining the currentusefulness of and indications for car-
diovascularradionuclideimaging, and itsrecommendations
are the subject of this report. Because of themultitude,
complexity and cost of currentlyavailableradionuclideim-
aging techniques, the Subcommittee has included recom-
mendationsregardingthe usefulness of various nuclearim-
aging techniques in patients with specific types of
cardiovasculardisease. With continuing research and de-
velopment, some of these recommendationsmay be subject
to modification, even in the near future.
The usefulness of cardiovascularimaging techniques in
specific disease states will be indicated in this report using
the following classification:
Class I: Frequentlyindicatedand oftenprovidesimportant
clinical information.
Class 1/: May addpertinentclinical informationin certain
subsets of patients.
Class //I: Occasionallyprovidesusefulclinicalinformation
and issometimesused as analternativediagnostictech-
nique.
Class IV: Not recommendedas a diagnostic technique.
Class V: Currentlyconsidereda researchtool.
In consideringthe use of a specificcardiovascularradio-
nuclide technique in individual patients, the following fac-
tors areimportant:
I. the qualityof the availablelaboratoryfor performingthe
study;
2. the sensitivity, specificity and accuracyof the technique;
3. the cost andaccuracyof the techniqueas comparedwith
otherdiagnostic procedures;and
4. the effect of positive or negative results on subsequent
clinical decision-making.
The format of thisreportincludes a brief descriptionof
specific nuclearcardiologic techniques, followed by a dis-
cussion of the usefulnessof radionuclideimaging in specific
cardiovasculardisease, each considering the utility of im-
aging for: I)diagnosis, 2) managementand itsassessment,
and 3) risk stratificationfor rehabilitation,occupation and
prognosis. A complete list of the multiple publicationson
cardiacimaging isbeyondthe scope of thiscommunication,
and only selected references are included.
Description of Specific Procedures
Most current nuclearcardiology applications utilize a
gamma camera of either: I) the single crystal type, or 2)
the multicrystal type. The single crystal gamma camera
(Anger camera) is the most widelyavailable system; it is
technically good for generating most of the clinically im-
portant nuclearcardiology information,that is, equilibrium
(gated) blood poolscanning,myocardialperfusionimaging,
myocardial infarct-avid imaging and lung scanning. The
multierystal camera has a somewhat lesser resolution, but
is generally a more sensitive device; thus, it is used for
"first pass" radiotracerstudies. The positron camera, or
positron emission tomographic (PET) scanner,is less widely
available and is used as aresearchtool. It holds considerable
promise as a tool formeasurementsof regional blood flow,
metabolism, cardiac receptors andmembranefunction.
To place radionuclideproceduresof the cardiovascular
system into clinical perspective, it is necessary to have a
basic understandingof the other diagnostic imaging tech-
nologies, which include echocardiography,digital subtrac-
tion angiography (DSA), high speed computed X-ray to-
mography and nuclear magneticresonance(NMR) imaging.
Echocardiography is somewhat less expensive and has sev-
eral technologic advantagesand some disadvantageswhen
comparedwith radionuclideprocedures.Digital subtraction
angiography and high speedcomputed X-ray tomography
utilize radiographictechnology, and theirprecise role in the
noninvasiveevaluationof the cardiovascularsystem has not
yet been defined. However, digital subtractionangiography
is useful for thediagnosis of pulmonaryembolism, partic-
ularly with a central injection ofcontrastmedium.
Nuclear magnetic resonance (NMR) imaging utilizes
nonionizingmagnetic and radiofrequencyfields to generate
images. While nuclearmagnetic resonance imaging appli-
cations to thecardiovascularsystem arecurrentlylargely in
a research phase, it has great promise as a means of defining
cardiovascularmorphology and function.
I. Gamma Camera Imaging (Single
Photon Approaches)
A. Radionuclide angiocardiography (RNA)
I. "First pass" approach (rest, stress). First pass radio-
nuclide angiocardiography (hereafter termed radio-
nuclide angiography)(4) utilizes rapidlyacquiredimage
frames toobserve a bolus of technetium-99m(Tc-99m)
as it moves through the venous system into the right
atrium, right ventricle, pulmonary artery, lungs, left atrium
and left ventricle. Since thesamplingrate is short relative
to the RR interval, it ispossible to sample continuously
several cardiac cycles as the bolus passes through the
right and then the leftventricle. By determining the
change inradioactivityover time (time-activitycurves),
it is possible to derive reliableejection fraction mea-
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surementsfrom both the right and the leftventricle. It
is also possible to approximateventricularvolumes, pul-
monary blood volume and regional wall motion. The
first pass approachis uniquely well suited for shunt de-
tection and quantitation.Left to rightshuntscan bequan-
titated by application of a mathematicalapproachto a
region of interest placed over the right lung known as
"gammavariate analysis" (5). It can be applied to pa-
tients both at rest andduringexercise stress.
2. Equilibrium gated blood pool radionuclide angiography
(rest. stress). Equilibriumgated blood poolradionuclide
angiographymost commonly utilizes technetiumbound
to red blood cells. Accordingly, technetium remains within
the blood pool, and serial imaging studies can be ac-
quired over several hours. Acquisition of the images is
synchronizedwith a markerof the cardiac period, such
as the electrocardiographicQRS complex. Using the
multigatedacquistion(MUGA) approach(6), every car-
diac cycle is divided into numerousframes. All the cycles
within a given RR interval range are addedtogetherfor
an imaging interval ranging from 2 to 10 minutes. The
resultantstudy providescomposite images of all the car-
diac cycles during the interval. The equilibriumblood
pool approachgeneratesreliable left ventricularejection
fraction values and a means for assessing regional wall
motion. It can be appliedboth at rest andduringexercise
stress. In addition, it has been reportedto be of value
in the estimation of right ventricularejection fraction,
ventricularvolumes, pulmonaryblood volume changes
with exercise and valvularregurgitantfraction.
3. Comparison between "first pass" and equilibrium
radionuclide angiographicapproaches. The''firstpass"
method appearsbetterfor determiningthe right ventric-
ular ejection fraction, because the data are not con-
founded by the overlap of left ventricularblood pool
activityas in theequilibriumapproach.Because first pass
studies sample only a very few cardiaccycles, transient
effects of exercise stress on ventricularperformanceare
betterdetected by this technique. However, the equilib-
rium radionuclideangiographicapproachgenerates im-
ages with higher resolution and better signal to noise
ratios.
4. Nonimaging nuclear probe.The nonimaging nuclear probe
or "nuclearstethoscope"uses a detectiondevice placed
over the region of the left ventricle. The device is small
and hasrelatively high sensitivity, but generatesno im-
ages. Optimal positioning for reliable left ventricular
functional measurements may be difficult. Although some
interesting research data have been derived using the
nuclear stethoscope, its relative clinical utility remains
uncertain.
B. Myocardial(perfusion) imaging
I. Intravenously administered tracer. A unique aspect of
nuclearcardiology is the ability to image regional myo-
cardialblood flow distribution.Thallium-201 is currently
the radionuclide of choice and is very efficiently ex-
tractedby viable myocardialcells (3). After intravenous
administration,the thalliumdistributesin proportionto
regional blood flow. Images of the heart shortly after
thallium administrationshow deficits in regions where
blood flow isrelativelyreducedand inzones of nonviable
myocardium(for example, priormyocardialinfarction).
Over time, "redistribution"occurs that results in dis-
appearanceof defects related to ischemic myocardium
but persistenceof defects related to infarctedor scarred
myocardium. The major problem with thallium-201 is
its suboptimal energy for clinical gamma camera im-
aging. Attenuationfrom bone, breast,the overlyingright
ventricularblood pool and diaphragmcan lead to the
appearanceof "defects"that may beinterpretedas pos-
itive studies by inexperiencedobservers. Also, thallium-
201 has a relatively long half-life of 73.5 hours in con-
trast to that oftechnetium-99m(6 hours). Several groups
have developed computerizedquantitativemethods for
more objective interpretationof thallium images. These
approachesassess regional homogeneity and the rate at
which thallium-201 decreases in regions of myocardium
over time. Such computerizationof serial images has
resulted in more consistent interpretation.Assessment
of lung thallium-201 uptake on the initialunprocessed
anteriorview image is used for indirectdetection of an
exercise-induced increase in left heart filling pressure
(7). Thalliumstudiescan beperformedat rest, with stress
or after themyocardial hyperemia induced by intrave-
nous administrationof dipyridamole. Myocardial per-
fusion imaging is most commonly employed in con-
junction with exercise stress, with thallium-20I being
administeredthrough an intravenousline at peak exer-
cise. The patient is then exercised for an additional 30
to 60 seconds, and images generally are acquiredin the
anteriorand several left anterioroblique projectionsim-
mediately after and again 3 to 4 hoursafter thallium
administration.In patients in stable condition who are
unable toexercise, dipyridamolehas been used toinduce
myocardialhyperemia,with subsequentregional inhom-
ogeneities in the perfusion patternrelated to coronary
stenoses (8-10). Studies have also been performedwith
stress inducedby atrialpacing. Such anapproachappears
less optimal than the use ofexercise or dipyridamole.
Finally, in patientswith unstableangina,a thalliumstudy
can beperformedat rest. As withexercise, serial imaging
both withdipyridamoleand at restallows demonstration
of "redistribution"in regions of ischemic or underper-
fused but viable myocardium (10,11). More recently,
thalliumstudieshave been performedin conjunctionwith
single photonemission computedtomography(SPECT).
This approachis consideredexperimentalat the present
time.
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2. Tracer administered during left heart catheterization.
Two approachesused for evaluationof myocardial per-
fusion during left heartcatheterizationare: I) the xenon
washout method, and 2) administrationof albumin mi-
crospheresdirectly into the coronary arteries. These ap-
proaches are nolonger widely applied and should be
consideredresearch procedures.
C. Myocardial infarct-avid imaging
Anotherunique aspect ofradionuclideimaging involves
the administrationof technetium-99m(stannous) pyrophos-
phate for imaging myocardial infarction. This agent is lo-
calized in zones of recently infarctedmyocardiumon gamma
cameraimages. The most intense visualization of infarcted
regions usually occurs 48 to 72 hours afterinfarction.This
techniqueis most useful when patients present later than 24
hours after the onsetof chest pain when enzymes and the
electrocardiogram may be more difficult to interpret. A newer
research approach tomyocardial infarct-avid imaging in-
volves the administrationof isotope-taggedspecific antibody
to cardiac myosin.
D. Myocardial metabolic imaging
Radionuclide (iodine-123)-labeled fatty acid has been used
for myocardial imaging and is currently a research tech-
nique. Considerablymore experience is available using the
positroncamerawith agents such ascarbon-IIpalmitic acid
and fluorine-If deoxyglucose.
E. Lung scanning
Lung perfusioncan be evaluatedusing intravenously ad-
ministered technetium-99m-labeledalbumin macroaggre-
gates ormicrospheres.These lodge in small pulmonary ves-
sels in proportionto perfusion, and significant defects may
representeither relatively reduced pulmonary perfusion or
the lack ofpulmonarytissues (forexample, emphysematous
blebs). Ventilation studies are performed in conjunction with
perfusionstudies using inhaledradioactivexenon. The ven-
tilation studiesdemonstratethe regionaldistributionof pul-
monary tissue so that defects intechnetium-99m micro-
sphere distributioncan be more appropriatelyinterpreted.
Technetium-labeledalbumin microspheresor macroaggre-
gates appearin the brain and splanchnic viscera after intra-
venous injection in the presenceof right to left intracardiac
shunting. Accordingly, right to left shunts may be detected
using this radionuclidemethod (5).
F. Miscellaneous procedures
Otherradionuclidemethods that have been applied to the
evaluationof the cardiovascularsystem but are yet unproved
include: 1) myocardialreceptor imaging, 2) thrombus im-
aging (for example, with radiolabeled platelets), and 3)
myocardial imaging with gallium-67 for detection of my-
ocarditis.
G. (Single photon) emission computed tomography
(SPECT)
This modality is capable of generatingcross-sectional
images of the heart. There are two approaches: I) application
of a multi-aperturedcollimatorto a wide field Anger camera
(for example, the "seven pin-hole collimator"),with the
heart viewed from several limited angles, and 2) transaxial
tomography using an Angercamerathat is rotated around
the individual so that images can be acquired at various
angles relative to the heart. Acomputerassembles the var-
ious projections to allowreconstructionof multiple tomo-
graphic planesperpendicularto the surface of the gamma
camera.
II. Positron Camera Imaging(Positron Emission
Tomography or PET)
Positron emission (computed)tomographyuses radiotra-
cers that generate high energy gamma photons on the basis
of positron-electronannihilation.For every positron anni-
hilation, there are two high energy (511 KeY) gamma pho-
tons released that travel in oppositedirections. Therefore,
it is possible to generatetomographicimages with photons
that are notsubstantially attenuatedby overlying tissue.
Accordingly, the intensity of activity in a positron image is
a more reliable reflection of the quantity of activity within
the heart than isobtainedwith the single photonapproaches.
Despite the several advantages of positronemission to-
mography, it is currently expensive, requires specialized
technologic support personnel and for optimal use is usually
in close proximity to acyclotron. Applications for which
positron imaging has been used includemyocardialperfu-
sion imaging (forexample, using rubidium-82, rubidium-
81, [nitrogen-l3]ammonia),myocardial metabolic imaging
(for example, carbon-II palmitate, f1uorine-18 fluorode-
oxyglucose), shunt detection andquantitation,pulmonary
blood volume andpulmonaryembolism imaging. Because
rubidium-82 is generated without a cyclotron, it is being
investigated as a positron imaging strategy with potential
for more widespreadclinical applicability.
III. Nuclear Magnetic Resonance (NMR) Imaging"
This relatively new technology bears littlesimilarity to
the radionuclide methods. Nevertheless, it is briefly de-
scribed because of itsincreasingprevalenceas an imaging
tool. The method takes advantage of themagneticproperties
ofcertain atomic nuclei, the mostimportantbeing the proton
or hydrogen nucleus, because hydrogen nuclei are abundant
in the water and fats of the body and emit a strong nuclear
magnetic resonance signal.Nuclearmagnetic resonanceim-
aging generates high resolutiontomographic or three-di-
mensional images with no ionizingradiation.Also, motion
generally reduces the signal in anuclearmagnetic resonance
*Magnetic resonance imaging (MRI), although a popular term, is not
acceptable to most scientists because the nucleus is principally responsible
for the generation of the images. Thus, the scientifically accurate nomen-
clature is nuclear magnetic resonance (NMR) or nuclear magnetic reso-
nance imaging (NMRI).
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image, and blood flowing through blood vesselsproduces
excellent contrastbetween the lumen of the vessel and its
more stationary surrounding tissue ,providingthe basis for
cineangiographywithout contrast medium. However, this
technology is very expensive and , at thepresent time , is
considered to be in its research phase for cardiovascular
applications.
IV . Other Diagnostic Imaging Technologies
A. Echocardiography
This is a cost-effective imaging technology for the car-
diovascular system. Without ionizing radiation,echocardi-
ography is capable of generatingimages of the cardiovas-
cular system with high spatial and timeresolution. It can
visualize myocardium,blood vessels and valve structures.
With two-dimensionalapproaches, the technique is capable
of generating tomographicviews of the heart; usingDoppler
methods , images candepict abnormalblood flow velocities
induced by stenotic or regurgit ant valvular lesions as well
as congenital lesions. Color coding of the Doppler signal
provides a means of determining direction of flow.
B. Digital subtractionangiography
Application of the computer to angiographic method s
results in excellent image sof the cardiovascular system with
lesser concentrationsof contrastmedium. This radiographic
approach, known as digital subtraction angiography, has
been investigated as a potential " noninvasive" method in
conjunction with intravenouscontrast medium ;however,
becau se of the large amountof contrast medium required ,
it appears to be most useful inconjunction with catheter-
angiographic methods. Digitial subtractionangiographyis
an importanttechniquefor the detection of pulmonaryem-
boli when contrastmedium is injected centrally.
C. High speed computed X-raytomography
This techniqueuses a new computed tomographictech-
nology capable of generating within tens of milliseconds
images of the cardiovascular system afterintravenous in-
jection of radiographiccontrast medium . It currently is in
its research phase .
Clinical Uses of RadionuclideImaging
Ischemic Heart Disease
I. Acute ischemic heart disease
A. Diagnosis
I . Angina at rest (unstable and variant angina).Clinical
use of radionuclideimaging in the diagnosisof unstable
and variantangina is limited. Diagnosis should be made
primarily by the history and electrocardiographic changes
of ischemia. The major objective is todemonstratere-
versible manifestations of myocardial ischemia during
chest discomfort.Thus, reversible, decreasedsegmental
myocardial perfusion defects detected by thallium-20l
myocardial imaging may aid in the diagnosis of rest
angina (class II). Howe ver, logisticproblems reduce the
clinical applicability of thallium imaging. Reversible
segmental wall motion abnormalities also indicate re-
versible myocardialischemia. Althoughradionuclidean-
giography is a sensiti vetechnique for detecting regional
wall motion abnormalities , its utilization in thediagnosis
of unstable or variant angina is limited (class III) , be-
cause it must be appliedduringchest pain andcompared
with studies without chest pain. Two -dimensional echo-
cardiography is more appli cable in the clinical settin g
for thispurpose. In unusu alcircumstances,as in patients
with prolongedchest discomfort or anondiagnosticelec-
trocardiogram(bundle branch block, intraventricular
conduction defects), detection of reversible segmental
perfusion defects by thallium-201 myocardial imaging
or reversible segmental wall motion abnormalities by
radionucl ide angio graphy can be useful adjuncts for the
diagnosis of unstable or variant angina.
2. Acute myocardial infarction (Table I ).Clinical use of
radionucJide imaging in the diagnosi sof acute myo-
cardial infarction is limited .Myocardial infarct-avid
scintigraphy using pyrophosphate hasmoderatesensitiv-
ity and specificity in the diagnosisof acute , particularly
transmural ,myocardial necrosis. Localized uptake of
technetium-99m pyrophosphate usuallyindicates acute
myocardial necrosis but can also occur inpatients with
intracardiac calcification, ventricular aneurysm and, rarely,
endocarditis. False negative results are frequent if the
test is performedearly «24 hours) or late(>7 days)
after the onsetof infarction . Falsenegative results occur
Table l. Diagnosis of Acute MyocardialInfarction-
Usefulness of RadionuclideImaging
I. Com patible clinical history . nondiagnostic electrocardiogram. serum
enzymes negative and late (2 to 7days) presentation-technetium-99m
pyrophosphate scan (class II).
2. Compatible cl inical history, nondiagnostic electrocardiog ram. serum
enzymes negative and early (first 6 hours) presentat ion-thallium-201
myocardial imaging (class III).
3. Clinical signs sugges ting right ventricular infarction, including
compatible physical findings . electrocard iographic chan ges and early
presenta tion- radionuclide angiography (class II).
4 . Right ventricular infarct ion with compatible physical findings.
electrocardiographic changes and presentation after 24
hours- technetium -99m pyroph osphate scan (class III) .
5 . Right ventricular infarct ion with low input state and hemodynami cs
simulating constrictive pericarditis-echocardiograph y or radionuclide
angiography (class III).
6 . Evolving infarction with reciprocal ST segment changes- radionuclide
angiog raphy (class III) and thallium-201 myoca rdial imag ing
(class III).
7 . Perioperativ emyocardial infarction in patientsundergoingcoronary
arter y bypass graft surgery (in the abse nce of new Q waves and with
significant elevation of serum enzymes) - technetium-99m
pyrophosphate scan (class II) .
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RNA = radionuclideangiography.
Table 2. Complicationsof AcuteMyocardialInfarction-
Usefulness of RadionuclideImaging
in many patients with a small infarct. The localization
of an acute leftventricularmyocardialinfarctionis fea-
sible with pyrophosphatescintigraphy, and right ven-
tricularinfarctioncan sometimes be identified (12). Dif-
fuse uptake mayindicate a non-Q wave infarction, but
its predictive value is poor.
Decreased thallium-201 uptake is indicative of re-
duced myocardial perfusion or myocardial infarction.
Localizedthalliumperfusiondeficits occurin a very high
percent of patients with acute (left ventricular) myo-
cardial infarction when the test isperformedwithin 16
hours of the onset of the infarction.The positivity of the
test may decline, however, when it is performedlater.
Such a positive test does not distinguish between acute
ischemia, acute infarctionor older infarction. However,
the presenceof "redistribution"on delayed images sug-
gests ischemia, ratherthan infarctionor scar. Regional
wall motion abnormalitiesdetected by radionuclidean-
giographyor echocardiographyare not specific for acute
myocardial necrosis. However, radionuclide angiog-
raphy often demonstrates a reduced right ventricular
ejection fraction and right ventricularasynergy in pa-
tients with right ventricularinfarction.
Clinical presentation, electrocardiographicchanges
and changes in serum enzymes are the mostcost-effec-
tive methods for the diagnosis of acute myocardial in-
farction. Electrocardiographiclocalization of infarction
is relatively sensitive and less expensive. However, un-
der certainclinical circumstances(13), radionuclideim-
aging can be recommendedfor the diagnosis and local-
ization of acute myocardial infarction(Table I).
Radionuclidetechniquesare useful indeterminingthe
presence or absence of several complicationsassociated
with acute myocardialinfarction(Table 2), such as im-
paired left and rightventricularfunction andrecurrent
myocardial ischemia. The diagnosis of left ventricular
aneurysm and pseudoaneurysmis feasible with radio-
nuclide angiography(3, 14). Radionuclideimagingplays
a secondaryrole in theassessmentof infarct-relatedven-
RNA = radionuclideangiography.
Thallium-20I myocardial imaging
(class II); RNA (class III)
RNA (class III)
RNA regurgitationindex (class
Ill)
RNA "first pass" shunt
quanti tation (class II)
RNA (class II); thallium-201
myocardial imaging (class Ill)
S. Reperfusiontherapy
I. Rest angina pectoris
2. Acute myocardial infarction
3. Mitral regurgitation
4. Ventricularseptal defect
Table 3. Managementand ItsAssessment-Usefulnessof
RadionuclideImaging
tricularseptal defect, mitralregurgitation,left ventricular
thrombusand pericardialeffusion (3,15).
B. Managementand its assessment (Table 3)
I. Rest angina. Myocardialimaging with thallium-20I may
be useful in assessing the viability of myocardial seg-
ments shown to beasynergic by other methods.
2. Acute myocardial infarction. Determining changes in
right and leftventricularfunction by radionuclide an-
giography in response to therapeuticinterventionsmay
be useful in certain patients.
3. Complications of acute myocardial infarction. Radio-
nuclide angiographymay be useful fordetectingchanges
during therapyin patients with severe mitralregurgita-
tion, ventricularseptal rupture orpseudoaneurysm.
4. Reperfusion therapy. Radionuclide angiography often
provides useful informationregardingchanges in global
or regional ventricularfunction. Thalliumuptake before
and after reperfusion may provide an estimate of the
volume of myocardiumreperfused.
C. Risk stratificationfor rehabilitation,occupation
and prognosis (Table 4)
The lateprognosisof patientsafter myocardialinfarction
is inftuenced by theextent of depressionof left ventricular
function, the presence or absence of recurrentmyocardial
ischemia, evidence of high gradeventricularectopic rhythm
or a combinationof these factors. Themeasurementof rest
andexercise left ventricularejectionfractionbefore hospital
discharge is most frequentlyobtainedby equilibriumgated
radionuclideangiography(16).
The additionof thallium-201 myocardialscintigraphyhas
been shown toimprove the predictivevalue of submaximal
stress electrocardiographyfor detecting ischemia in post-
infarction patients (17,18). In addition, the appearanceof
increasedlung thalliumactivity with exercise stress studies
appears to indicate moreadvancedleft ventriculardysfunc-
tion and may beassociated with a poorer prognosis. Re-
cently, thallium-201 administrationduringdipyridamolein-
fusion has been reportedto be useful in identifying high
risk patients.
For rehabilitationpurposesor todeterminework capacity
after a recent myocardial infarction, radionuclideimaging
RNA (class I)
RNA (class I)
EquilibriumRNA for regurgitant
fraction (class III)
First pass RNA for shunt
detection (class II)
RNA (class IV)
Thallium-201 myocardial imaging
(class II) or equilibriumRNA
(class III)
I. Left ventricularfailure
2. Left ventricularaneurysmand
pseudoaneurysm
3. Mitral regurgitation
4. Ventricularseptal rupture
S. Left ventricularthrombus,
pericardialeffusion
6. Postinfarctionangina
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Table 4. Decision-Making After Myocardial Infarction-Usefulness of Radionuclidc Imaging
I. Determi nation of high riskpatients
2. Decisions regardin g rehabilitation
3. Decisions regarding return to work
Predischar ge rest RNA (classII) and exercise RNA (class 1II);
predi scharge submaximalexercise thallium-201 myocardial
imaging (class II-II\); dipyridamole thallium-20 I myocardial
imaging pred ischarge (class V);* symptom-limited thallium-20 t
scan at 4 to 8 weeks (class II)
RNA (class V); exercise thallium-201 imaging (class V)
RNA (class V); exercise thallium-20t imaging (class V)
RNA = radionuclideangiography. *As of this writ ing. neither intravenous nor oral dipyridam ole is approved
by the U.S . Food and Drug Admini stration for this purpose.
is not required. A standardexercise stress test usually pro-
vides sufficient information for decisionsregarding reha-
bilitationand return to work .
II. Chronic ischemic heart disease (Table 5)
A. Diagnosis
I . Angina pectoris . Rest and exerci sethallium-20I myo-
cardialimaging is useful in patients suspected of having
ischemic heart disease on the basis of the history or
electrocardiogram, or both (3,19-22). It is particularly
useful for assessing the presence and severity of ischemic
heart disease under the followingconditions:
Table 5. Chronic Ischemic Heart Disease-Usefulness of
Radionuclide Imaging
l. Diagnosis of symptomatic Exercise thallium-201 imaging
myocard ial ischemia (class I-II ); exercise RNA
(class II-Ill); PET (class V)
2. Detect ion of silent myocardial Exercise thallium-20l imaging
ischemi a (class I-II); exercise RNA
(class II-III); PET (class V)
3. Diagnosis of remote Exerci se thallium-20l imaging
myocardial infarction (class II ); exercise RNA (class
1Il )
4 . Follow-up after PTCA or Exercise thallium -201 imaging
CABG (class I) ; exercise RNA (class
II )
5. Assessment of ventricular RNA (class \)
performance
6. Viability of asynergic left Exercise thallium-201 imaging
ventricular seg ments (class II )
7. Planning myoca rdial Exercise thallium -20l imaging
revascularization (class II ); exercise RNA [left
ventricular function] (classI )
8. Assessment of therapy
(a) Ventricularperformance RNA (class I-II)
(b) Myocardial perfusion Exercise thall ium-201 imaging
(class I-II)
9. Risk stratification Exercise thallium-20I imagin g
(class II ); exercise RNA (class
II)
CABG = coronaryartery bypass graft ing: PET= positron emission
tomography ; PTCA = percutaneous transluminal coronary angioplasty;
RNA = radionuclideangiography.
(a) Equivocal electrocardiographicST-T wave abnor-
malities arepresent in patients withconduction ab-
normalitiesor drugeffects. Thalliumstudies may be
less sensitive and specific when ST-T wavechanges
are associated with left ventricularhypertrophy.
(b) Symptomaticpatientshave a negative electrocardio-
graphic response during exerci seinsufficient to in-
crease heart rate to 85% or more ofpredictedmax-
imum.
(c) There is a likelihood of false positive electrocardio-
graphic exercise abnormalities.
(d) Patients have exercise-induced chest discomfort
without electrocardiographic changes.
In addition, thallium imaging is useful for these pur-
poses:
(a) Serial assessment of progre ssion of disease in pa-
tients with knowncoronaryarterydisease.
(b) Furtherdefinition of the high risk patient.
(c) Evaluationof the response tomedical, angioplasty
or surgical therapy.
Utilizing Bayes' theorem,thediagnosticvalue ofthal-
lium imaging is greatest in patients with a moderate
pretest likelihood that ischemic heartdisease is respon-
sible for chest pain orelectrocardiographicchanges, or
both . This is, in part, because of the small but definite
incidence of false positive and false negative results of
thallium imaging fordetectingregional myocardialisch-
einia . Rest and exerci seradionuclideangiographyis use-
ful for assessing left ventricularejection fraction and
regional wall motion; thecombinationof an inadequate
rise « 5%) or a fall inejection fraction plus regional
wall motion abnormalities appearing as a new event or
worsening with exerci se is quite specific for ischemic
heart disease but relativel y insensitive (3). Bycontrast,
if an abnormalejection fraction response to exerci se is
the sole criterionfor a positive result , the test is more
sensitive but less specific (3,23- 26). Rest andexercise
radionuclideangiographycan be used as analternative
study to thallium imaging for thepurposes listed . Pos-
itron emission computed tomographywith agents such
as rubidium-82has been used to depictmyocardialper-
fusion abnormalitiesbut is currently aresearch tech-
nique.
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RNA = radionuclideangiography.
Table 6. Valvular HeartDisease-Usefulness of
Radionuclide Imaging
nuclide angiographyand thalliumimaging, respectively.
Successful revascularizationmay be demonstratedby
serial thallium imaging.Radionuclideand nuclear mag-
netic resonance studies ofmyocardial metabolism for
assessing therapy arecurrentlyresearch procedures.
3. Risk stratification for rehabilitation, occupation and
prognosis. Permissible levels of activity and prognosis
in patients with ischemic heart disease depend on the
extent of myocardial ischemia and impaired left ven-
tricular function. Thus,thallium-20l myocardial imag-
ing and radionuclideangiography are often useful for
evaluatingprognosis, rehabilitationand work status be-
fore and after therapy.
Valvular Heart Disease
A. Diagnosis
Both first pass andequilibriumradionuclideangiography
have been used to assess theseverity of aortic or mitral
regurgitation,or both (31). Thedifference in stroke counts
between the right and left ventricles provides an index of
the extent of volume overload in the absence of tricuspid
regurgitation.The regurgitantfraction in a patient with left
ventricularvolume overload can beapproximatedusing the
stroke counts of the left ventricle minus the stroke counts
of the right ventricle. Difficulty inseparatingthe counts
fromenlargedventricles and atria limits the accuracy of this
method. Both cardiaccatheterizationwith cineangiocar-
diography andDopplerechocardiographyprovide more re-
liable information (Table 6).
Radionuclideangiographyprovides a means to reliably
evaluate left ventricularejection fraction in patients with
valve disease. First pass andequilibriumradionuclidean-
giography can be used todetermine the right ventricular
ejection fraction.Inflammationof the heart valves and other
cardiac structures is associated withaccumulationof white
Rest RNA (class I); exercise RNA
(class V)
RNA (class III)
Imaging withgallium-67 or
indium-Ill-labeledplatelets
(class V)
RNA (class IV)
ThalliUm-20l scan (class III); rest
and exercise RNA (class IV)
I. Detection andquantitationof
aortic and/or mitral
regurgitation
2. Initial and serialassessment of
left and rightventricular
performance
3. Detection of inflammation of
the heart and valves
4. Detection of aorticdissection
and its complications
5. Detection of concomitant
coronary artery disease
2. Detection ofasymptomatic disease. When asymptomatic
or silent myocardial ischemia is suspected in a patient
without known coronaryartery disease, either rest and
exercise thallium imaging or rest and exercise radio-
nuclide angiographycan provide useful clinical infor-
mation. Both tests are more useful fordocumentingmyo-
cardial ischemia in patientswith known coronary artery
disease who haveasymptomaticepisodes of ST segment
depression (27). Positron emission tomography using
rubidium-82(half-life = 75 seconds) or other agents has
also been used todemonstrateperfusion abnormalities
associated with silent ST segmentdepression.
3. Remote myocardial infarction.With thallium-20l myo-
cardial imaging, previous myocardialinfarction is dem-
onstratedby reduced activity of isotope in the region of
scar and by the lack ofredistributionto the site on de-
layed images. Radionuclideangiographywill commonly
demonstratesegmental wall motionabnormalities.
4. Long-termfollow-upafter myocardial revascularization.
Both thallium-20l myocardial imaging andradionuclide
angiographyare useful forassessing patients after coro-
nary artery bypass graftsurgery, angioplasty or throm-
bolytic therapy(28-30). Comparisonwith radionuclide
studies beforerevascularizationis useful but not always
available.
5. Myocardial viability and ventricular performance.The
viability (potentialreversibility)of abnormallycontract-
ing myocardial segments supplied by stenotic coronary
arteries can be assessed by serial thallium imaging at
rest and duringexercise or afteradministrationof intra-
venous dipyridamole.Radionuclideangiographyis use-
ful for assessing global and segmentalventricularper-
formance at rest and during exercise testing or during
rapid atrial pacing. As notedpreviously, the presence of
significant lung thallium activity on initialpostexercise
thallium imaging studies indicates leftventriculardys-
function.
B. Management and its assessment
I. Role in therapeutic decision-making. Decisions about
medical and surgicaltreatmentcan usually be influenced
importantlyby combining informationabout the extent
of coronaryatherosclerosiswith measurementsof ven-
tricular performance using radionuclide angiography. The
demonstrationof ischemia by thallium imaging can be
importantwhen deciding whetheror not torevascularize
an areaof myocardiumdistal to coronary artery stenosis.
Studies of myocardial metabolism using radionuclide
techniques(for example, iodine-123-labeledfatty acids
or fluorine-18-labeledftuorodeoxyglucose) are promis-
ing but are not widely available and should beconsidered
as research techniques at the present time.
2. Assessment of therapy. Change in regional and global
ventricularperformanceand regional myocardial per-
fusion afteran interventioncan be assessed using radio-
JACC Vol. 8. No. 6
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RNA = radionuclide angiography.
Table 7. Cardiomyopathies-Usefulness of
Radionuclide Imaging
Myocarditis and Cardiomyopathy
I. Myocarditis
A. Diagnosis
The diagnosis of myocardit is generally can be establi shed
on the basis of a careful history, physicalexamination,
electrocardiogram and chest X-ray study.Endomyocardial
biopsy is useful in selected patients to confirm the diagnosis.
The presence of myocardial inflammation can be assessed
using radionuclides that are extracted by involved myocar-
dium (Table 7). Bothgallium-67 citrate (33) and techne-
tium-99m pyrophosphatehave been used for thispurpose,
but both falsepositive and false negative results are com-
mon.
In patientssuspectedof havin gmyocarditis,radionuclide
angiography oftenprovides useful information bydetecting
left and rightventriculardysfunction. Although ventricular
dysfunction in acute myocarditis is generally diffuse and
results in generalized hypokinesia, isolated left or right ven-
tricular dysfunction may exist and regional wall motion
abnormalities may occur. Serial radionuclide angiography
has been useful for detecting depre ssionof left ventricular
function in patient s being treated with drugs (Adriamycin,
for example) that have the potential to cause left ventricular
dysfunction. Echocardiography provides an alternative tech-
nique and is better for detecting concomitant pericardial
effusion. With thallium imaging, fixed focal defect s are
occasionally found in patients with active myocarditis , but
usually there is a homogeneou s distribut ionof thall ium.
B. Managementand its assessment
The utility of serial gallium or technetium-99m pyro-
phosphate scans in the management ofpatients with myo-
carditis has not been establi shed ;however, in some cases,
cell s and platelets, which may be imaged withgallium-67
citrate andindium-I1l-labeled platelets, respecti vely. The
clinical value of these approaches is uncertainat the present
time .
Radionuclideimaging is of limited value fordiagnosing
pericardial effusion and aortic valve regurgitationsecondary
to aortic disection. X-ray computedtomographicscanning
(class II) andnuclearmagnetic resonance imaging (class V)
are promising new techniques. For this application, echo -
cardiography and contrast angiography are currently the most
effective diagnostic tools.
B. Managementand its assessment
Radionuclide angiography is of limited value for the
quantitativeassessment of mitral or aorticregurgitation,or
both , and other techniques are better . Decisions about the
timing of valve repairor replacement for aortic or mitral
regurgitationor aortic stenosis are often based on assessing
the effect of the valve lesion or lesions on ventricular per-
formance at rest. Thus,radionuclideangiography is useful
for determining ventricular ejection fractions in the initial
and serial evaluations of symptomatic and asymptomatic
patient s with severe valvular stenos is or regurgitation, or
both . The significance of a reduction , rather than an in-
crease, in left ventricular ejection fraction duringexercise
in patients with aortic or mitral regurgitation remains con-
troversial (32). There are few indications forthallium im-
aging in patients with valvular heart disease, although it is
sometimes used todiagnose and assess concomitant coro-
nary artery disease .Nevertheless, the reliabilit y and accu-
racy of positive and negat ive results arediminished in the
presence of ventricularhypertrophy or dilation , or both, and
under these circumstances, coron ary arteriographyis the
appropriate diagnostic method. Exercise radionuclide an-
giography also isof little value in detectingcoronarydisease
in such patients. Radionuclide angiography isof limited
value in assessing results of medical therapyon the severity
of aortic or mitralregurgitation but may provide useful
information on residualregurgitation in patients with recent
valve replacement. However, Doppler cchocardiography and
X-ray contrastcineangiography are preferred techniques.
The evaluationof left and right ventricularejectionfraction s
after valve repair or replacement can beprovidedby radio-
nuclide angiography. There are few indication s for assessing
chan ges in myocardial perfusion in patients treated medi-
call y or surgically forvalvularheart disease.
C. Risk stratificationfor rehabilitation, occupation
and prognosis
Myocardialperfusionimaging provides littleinformation
concerning riskstratification. Radionucl ideangiographic as-
sessment of right and left ventr icularejection fractions is
useful in makingdecisions concerningprognosis, post-treat-
mentrehabilitationand workstatus,whereas the valueofradio-
nuclide angiographywith exercise continues to be investi-
gated.
I . Demonstrating myocardial
inflammation and response to
therapy
2. Determining initial and serial
left and right ventricular
performance in myocarditis or
dilated cardiomyopathy
3. Differentiating ischemic heart
disease from dilated
cardiomyopathy
4. Establishing the diagnosis of
hypertrophic cardiomyopathy
5. Diagnosis of restrictive
cardiomyopathy
Gallium-67 imaging (classIII) or
technetium-99m pyrophosphate
imaging (class IV)
Rest RNA (class I-II); exercise
RNA (class V)
RNA (class III); thallium-201
imaging (class II )
RNA (class III) ; thallium-201
imaging (class IV)
RNA (class III); myocardial
imaging with technetium or
gallium (class Ill); thallium-201
(class IV)
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clinical improvement withimmunosuppressivetherapy has
correlated with a resolution of gallium uptake by the myo-
cardium. Because the morbidity and mortality of myocar-
ditis are largely related to the extent of ventricular dys-
function, radionuclide angiographic determinations of right
and left ventricular size and performance are valuable for
assessing the effects of management in such patients, but
thallium scans are of little value.
C. Risk stratificationfor rehabilitation,occupation
and prognosis
Because the three prognostic factors, ventricular dys-
function, ventricular arrhythmias and exercise tolerance, are
interrelated, severe ventricular dysfunction, as measured by
radionuclide angiography, is a marker of patients with a
poorer prognosis who may require a limited work and ac-
tivity prescription.
II. Dilated cardiomyopathies
A. Diagnosis
Determination of ventricular size and function using
radionuclide angiography is a useful technique in establish-
ing the diagnosis of dilated cardiomyopathy (34,35). Al-
though globalbiventriculardysfunction is usual, left ven-
tricular dysfunction is usually more advanced. Thallium
imaging most often reveals left ventricular dilation and ho-
mogeneous or diffusely inhomogeneous uptake. Large de-
fects (forexample,40% of the circumference) strongly favor
left ventricular dysfunction due to ischemic heart disease,
and a reversible defect usually indicates ischemia rather than
scar. However, large, fixed (particularly apical) defects have
been reported in patients with dilated cardiomyopathy.
Gallium-67 citrate and technetium-99m pyrophosphate
imaging have been used to detect active myocarditis in pa-
tients with apparent dilatedcardiomyopathy,but positive
scans also occur in patients with various forms of infiltrative
or degenerative heart disease. Scans may be negative in
patients with"myocarditis"on endomyocardial biopsy.
B. Managementand its assessment
Assessment of ventricular performance by radionuclide
angiography is useful for guiding the management of pa-
tients with dilated cardiomyopathy. Gallium-67 citrate im-
aging might be useful for assessing the response of ven-
tricular function toimmunosuppressivetherapy, but this
application requires further confirmation.
C. Risk stratificationfor rehabilitation,occupation
and prognosis
Determination of ventricular performance by radio-
nuclide angiography provides an excellent means of as-
sessing prognosis and activity guidelines in patients with
dilated cardiomyopathy.The value of exercise radionuclide
angiography requires further study. Gallium-67 and tech-
netium-99m pyrophosphate imaging and thallium imaging
are of little value for risk stratification.
III. Hypertrophic cardiomyopathies
A. Diagnosis
The diagnosis of hypertrophiccardiomyopathyalmost
always can be established on the basis of the clinical ex-
amination, electrocardiogram andechocardiographicstud-
ies. Radionuclide angiography frequently demonstrates cav-
ity obliteration,septalflattening,disproportionateupper septal
thickening or a filling defect in the left ventricular outflow
tract in patients with hypertrophic cardiomyopathy (36).
Asymmetric septal hypertrophy also may be detected by
thallium imaging by comparing septal thickness with that
of the posterior left ventricular free wall (37). The asym-
metric distribution of myocardial mass makes the detection
of ischemic heart disease difficult in the presence of hy-
pertrophic cardiomyopathy.
B. Managementand its assessment
Recent studies suggest that measurements of peak dia-
stolic left ventricular filling rates using radionuclide angi-
ography-derived high resolution time-activity curves may
be useful in guiding medical therapy in patients with hy-
pertrophiccardiomyopathyand impaireddiastolicfilling (38).
C. Risk stratificationfor rehabilitation,occupation
and prognosis
There are no current data to recommend radionuclide
imaging techniques for this purpose.
IV. Restrictive cardiomyopathies
A. Diagnosis
A variety of diagnostic procedures, including cardiac
catheterization, usually are necessary to establish the di-
agnosis. Characteristically,radionuclide angiography dem-
onstrates a normal or small ventricular size atend-diastole,
dilated atria and normal or mildly depressed ejection frac-
tions. Myocardial uptake oftechnetium-99mpyrophosphate
or gallium, or both, is common but can be due to various
conditions including amyloidosis,sarcoidosis, progressive
systemic sclerosis and cardiac tumors. Fixed defects in myo-
cardial thallium-201 images often occur in patients with
sarcoidosis, progressive systemic sclerosis or cardiac tumors
(3,39,40).
B. Managementand its assessment
Under special circumstances, serial measurements of
ventricular performance by radionuclide angiography may
be useful to document the effects of specific therapy (for
example, for hemosiderosis).
C. Risk stratificationfor rehabilitation,occupation
and prognosis
There are no current data to support the use of radio-
nuclide imaging techniques for this purpose.
Congenital Heart Disease With Shunting
A. Detection ofshunts (Table 8)
In left to right shunting, first pass radionuclide angiog-
raphy classically demonstrates high levels of activity in the
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lungs or rightventricle, or both, due to earlyrecirculation
(5). Resultant time-activity curves derived from different
chambers can be used to localize the level of the shunt.
Right to left shunts can be detected from inspection of the
radionuclideangiographicstudy, with earlyvisualizationof
either the left heartchambers or the aorta. Left to right
shunts can bequantitatedusing the ratio of the pulmonary
to systemic flow from thetime-activitycurve over the right
lung (class II). Quantitationappears to be more reliable
using Cl502 inhalationwith positroncameraimaging.
Radionuclide angiography provides useful information
about the influence of the shunt on left and rightventricular
performance. Lung perfusion scanning using intravenous
injection of microspheres ormacroaggregatesof albumin
may be used for quantitatingright to left shunting. Ap-
pearances of technetium activity in brain and splanchnic
viscera suggests right to left shunting. Pulmonary blood
volume can be evaluated using first passradionuclidean-
giography;however, its clinical usefulness is not clear.
Rest and exercise thallium-20l imaging can define ab-
normal perfusionpatterns in patients with anomalous coro-
nary arteries or other types ofcongenital heart disease in
which coronary blood flow may be regionallydiminished.
Echocardiography,properly applied, is the imaging method
of choice for evaluating patients with possiblecongenital
heart disease.
B. Managementand its assessment
Serial assessmentof shunt flow by first passradionuclide
angiography may reveal spontaneous closure, successful
surgical closure or residual left to right shunting. Patency
of palliative shunts can bedemonstratedby careful assess-
ment of pulmonarydilution curves or by pulmonary per-
fusion imaging. Evaluationof left and rightventricularejec-
tion fractions byradionuclideangiographymay be useful
in determiningthe optimal time for surgical correction in
patients with left or rightventricularpressure or volume
overload states and in relating anypostoperativesymptoms
to residual ventriculardysfunction.
C. Risk stratificationfor rehabilitation,occupation
and prognosis
The usefulness of radionuclideimaging, including rest
and exercise studies, for making decisions related to limi-
tation of activity and work status remains to be defined.
Pulmonary Vascular Disease
I. Pulmonary embolism
A. Diagnosis
Pulmonary perfusion scintigraphy (using technetium-
labeled albuminmacroaggregatesor microspheres)usually
with ventilation scintigraphy(xenon-133) is the preferred
noninvasive technique (Table 9) for the diagnosis of pul-
monary embolism (41-43). Acute pulmonary emboli usu-
ally produce sharplydelineatedpolysegmentalor lobar de-
fects, and most patients with pulmonary emboli have multiple
perfusion defects. Ventilationscintigraphyis useful for dis-
tinguishing between primaryperfusion abnormalitiesand
those secondary to regional hypoxia. Caution must be ex-
ercised in theinterpretationof these studies in patients with
severe chronic lung disease.Assessment of left and right
ventricularperformanceby radionuclideangiographymay
be useful for definingpredisposingventriculardysfunction
or resulting rightventriculardysfunction in patients with
definite or suspected pulmonaryembolism.
Iodine-125-labeledfibrinogen uptake can be useful for
diagnosing thrombophlebitisand small vein thrombi in pa-
tients at risk.Venographyusually provides more definitive
information.Indium-IIIplatelet imaging for detecting areas
of thrombosis requires furtherinvestigation.
B. Managementand its assessment
Serial pulmonary ventilation/perfusionscintigraphy is
useful fordeterminingresolution after acutepulmonaryem-
bolism and for assessing the effects ofthrombolytictherapy.
Also, such serial studies are useful in assessing the effec-
tiveness of anticoagulanttherapy. Leftventriculardysfunc-
tion predisposingto pulmonaryembolism can be detected
by radionuclideangiography.
C. Risk stratificationfor rehabilitation,occupation
and prognosis
Serial pulmonaryventilation/perfusionscans (class III)
and radionuclideangiography(class III) may be useful for
assessing residualabnormalitiesof rightventricularfunction
Table 8. CongenitalHeartDisease-Usefulness of
RadionuclideImaging Table 9. PulmonaryVascularDisease-Usefulness of
RadionuclideImaging
I. Detection and localization of
shunts
2. Quantitating left to right
shunting
3. Initial and serial assessment of
ventricular function
4. Diagnosing anomalies of the
coronary circulation
First pass RNA for left to right
shunts (class II) and for right to
left shunts (class III); lung
perfusion scanning (class III for
detection)
First pass RNA (class II);C150z
inhalation (class V);
RNA (class I-II)
Thallium-201 imaging (class III)
I. Detection of suspected
pulmonary embolism response
to therapy
2. Documenting effect of
pulmonary vascular disease on
right ventricular function
3. Detection of venous thrombus
or thrombophlebitis
Pulmonary ventilation perfusion
scintigraphy (classl)
First pass RNA (class II);
equilibrium RNA (class III)
Iodine-125-labeledfibrinogen
imaging (class III); indium-
III-labeledplatelet imaging
(class V)
RNA = radionuclide angiography. RNA = radionuclide angiography.
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or pulmonaryperfusion,or both, and the resulting data may
Influence decisions regarding patient activity.
II. Chronic obstructive pulmonary disease
A. Diagnosis
Because regional ventilation is usually equal to or de-
creased incomparisonwith perfusion in patients with acute
bronchospasmor chronic lung disease, pulmonary venti-
lation/perfusion scintigraphy, which can demonstrate re-
duced perfusion incomparisonwith ventilation, is useful in
detecting pulmonary emboli.
Rest radionuclideangiography can evaluate left ventric-
ular function and is therefore useful in distinguishing be-
tween pulmonarydisease and heart failure as a cause of
dyspnea (class II). However, it is important to note that
pulmonary function and leftventricularejection fraction
may be normal when dyspnea is due to leftventricular
diastolic dysfunction. Thallium imaging may be helpful in
determining whether chest discomfort in patients with chronic
lung disease is related tocoincident ischemic heart disease
(class II).
B. Management and its assessment
The efficacy of specific therapy on impaired right ven-
tricularperformancecan be determined by serial first pass
radionuclideangiography(class III). Also, the toxic effect
of amiodaronetherapy on the pulmonaryparenchymacan
be assessed by serial imaging with gallium (class III).
C. Risk stratificationfor rehabilitation,occupation
and prognosis
There are fewcurrentdata to support the use of radio-
nuclide imaging techniquesfor this purpose (class IV).
Hypertensive Heart Disease
A. Diagnosis
1. Ventricular performance. Radionuclide angiography at
rest is useful for assessing leftventricularsystolic func-
tion in patients withhypertension(class I). However,
echocardiography, unlike radionuclide angiography, also
is useful for evaluating left ventricular wall thickness.
Assessment of left ventricularpeak diastolic filling rates
by radionuclideangiography (44) may identify impaired
diastolic function when systolic function is normal (class
V).
In patients with leftventricularhypertrophy,thallium
imaging can be useful for detecting reversible defects
among those who have coexistent ischemic heart disease
(class II); however, it appears to be less reliable in pa-
tients with as compared to those without hypertrophy.
B. Management and its assessment
Radionuclide angiography is useful for evaluating the
effect of blood pressure reduction and other medical therapy
in patients with leftventriculardysfunction (class II).
C. Risk stratification forrehabilitation,occupation
and prognosis
Determination of leftventricularperformanceby radio-
nuclide angiography may influence decisionsconcerning
work status and extent of activity (class11).
Summary
This report describes the nuclear cardiology procedures
available for use as diagnostic techniques in patients with
definite or suspectedcardiovasculardisease. The usefulness
of myocardial imaging,radionuclideangiocardiographyand
other radionuclidecardiovascular imaging techniques is
classified within specific disease states. The clinical utility
of each technique is graded from I to IV, depending on the
clinical importance of the technique(I = most important;
IV = not indicated). A grade of V is given for methods
now considered to be in their research phase. The usefulness
of these methods is discussed in patients with acute ischemic
heart disease, chronic ischemic heartdisease, valvular heart
disease, pulmonary vascular disease andhypertensiveheart
disease. Selected references are provided.
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